Metabotropic glutamate receptor agonists stimulate polyphosphoinositide hydrolysis in primary cultures of rat hepatocytes. 1997

F Sureda, and A Copani, and V Bruno, and T Knöpfel, and G Meltzger, and F Nicoletti
I.M.N., Pozzilli, Italy.

The metabotropic glutamate (mGlu) receptor agonists, quisqualate and (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (ACPD), but not (RS)-3,5-dihydroxyphenylglycine or (2S,3S,4S)-alpha-(carboxycyclopropyl)glycine, stimulated [3H]inositolmonophosphate ([3H]InsP) formation in primary cultures of rat hepatocytes. 1S,3R-ACPD-stimulated [3H]InsP formation was inhibited by alpha-methyl-4-carboxyphenylglycine, indicating that cultured hepatocytes express functional mGlu receptors coupled to polyphosphoinositide hydrolysis. The identity of these receptors is not similar to that of any of the known mGlu receptor subtypes characterized in heterologous expression systems.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003515 Cycloleucine An amino acid formed by cyclization of leucine. It has cytostatic, immunosuppressive and antineoplastic activities. 1-Aminocyclopentanecarboxylic Acid,Aminocyclopentanecarboxylic Acid,NSC 1026,1 Aminocyclopentanecarboxylic Acid,Acid, 1-Aminocyclopentanecarboxylic,Acid, Aminocyclopentanecarboxylic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016318 Quisqualic Acid An agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium mobilization from intracellular stores. The compound is obtained from the seeds and fruit of Quisqualis chinensis. Quisqualate
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D018094 Receptors, Metabotropic Glutamate Cell surface proteins that bind glutamate and act through G-proteins to influence second messenger systems. Several types of metabotropic glutamate receptors have been cloned. They differ in pharmacology, distribution, and mechanisms of action. Glutamate Receptors, Metabotropic,Metabotropic Glutamate Receptors,Receptors, Glutamate, Metabotropic,Metabotropic Glutamate Receptor,Glutamate Receptor, Metabotropic,Receptor, Metabotropic Glutamate
D018129 Phosphatidylinositol Phosphates Phosphatidylinositols in which one or more alcohol group of the inositol has been substituted with a phosphate group. Polyphosphoinositides,Phosphatidyl Inositol Phosphates,Polyphosphoinositide,Inositol Phosphates, Phosphatidyl,Phosphates, Phosphatidyl Inositol,Phosphates, Phosphatidylinositol
D018690 Excitatory Amino Acid Agonists Drugs that bind to and activate excitatory amino acid receptors. Amino Acids, Excitatory, Agonists,Glutamate Agonists,Agonists, Excitatory Amino Acid,Amino Acid Agonist, Excitatory,Amino Acid Agonists, Excitatory,EAA Agonist,EAA Agonists,Excitatory Amino Acid Agonist,Glutamate Agonist,Agonist, EAA,Agonist, Glutamate,Agonists, EAA,Agonists, Glutamate
D018696 Neuroprotective Agents Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. Neuroprotectant,Neuroprotective Agent,Neuroprotective Drug,Neuroprotectants,Neuroprotective Drugs,Neuroprotective Effect,Neuroprotective Effects,Agent, Neuroprotective,Agents, Neuroprotective,Drug, Neuroprotective,Drugs, Neuroprotective,Effect, Neuroprotective,Effects, Neuroprotective

Related Publications

F Sureda, and A Copani, and V Bruno, and T Knöpfel, and G Meltzger, and F Nicoletti
January 1992, Journal of neurochemistry,
F Sureda, and A Copani, and V Bruno, and T Knöpfel, and G Meltzger, and F Nicoletti
March 1999, Brain research,
F Sureda, and A Copani, and V Bruno, and T Knöpfel, and G Meltzger, and F Nicoletti
December 1989, Biochemical Society transactions,
F Sureda, and A Copani, and V Bruno, and T Knöpfel, and G Meltzger, and F Nicoletti
November 2023, Neuropharmacology,
F Sureda, and A Copani, and V Bruno, and T Knöpfel, and G Meltzger, and F Nicoletti
April 1995, European journal of pharmacology,
F Sureda, and A Copani, and V Bruno, and T Knöpfel, and G Meltzger, and F Nicoletti
February 2008, The British journal of psychiatry : the journal of mental science,
F Sureda, and A Copani, and V Bruno, and T Knöpfel, and G Meltzger, and F Nicoletti
October 1992, Neuroreport,
F Sureda, and A Copani, and V Bruno, and T Knöpfel, and G Meltzger, and F Nicoletti
May 1996, Brain research. Developmental brain research,
F Sureda, and A Copani, and V Bruno, and T Knöpfel, and G Meltzger, and F Nicoletti
January 1997, The European journal of neuroscience,
F Sureda, and A Copani, and V Bruno, and T Knöpfel, and G Meltzger, and F Nicoletti
November 2000, British journal of pharmacology,
Copied contents to your clipboard!